| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-05 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-05 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.27 | 3e-05 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.17 | 7e-05 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-05 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-05 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.0001 |